Minoxidil sulfate

Last updated
Minoxidil sulfate
Minoxidil sulfate.svg
Clinical data
Other namesMinoxidil sulphate; Minoxidil sulfate ester; Minoxidil sulphate ester; Minoxidil N-O-sulfate; Minoxidil N-O-sulphate; U-58838
Identifiers
  • (2,6-diamino-4-piperidin-1-ylpyrimidin-1-ium-1-yl) sulfate
CAS Number
PubChem CID
ChemSpider
UNII
ChEBI
ChEMBL
ECHA InfoCard 100.163.834 OOjs UI icon edit-ltr-progressive.svg
Chemical and physical data
Formula C9H15N5O4S
Molar mass 289.31 g·mol−1
3D model (JSmol)
  • C1CCN(CC1)C2=NC(=[N+](C(=C2)N)OS(=O)(=O)[O-])N
  • InChI=1S/C9H15N5O4S/c10-7-6-8(13-4-2-1-3-5-13)12-9(11)14(7)18-19(15,16)17/h6H,1-5H2,(H4,10,11,12,15,16,17)
  • Key:OEOLOEUAGSPDLT-UHFFFAOYSA-N

Minoxidil sulfate, also known as minoxidil sulfate ester or minoxidil N-O-sulfate, is an active metabolite of minoxidil (Rogaine, Loniten, others) and is the active form of this agent. [1] [2] Minoxidil acts as a prodrug of minoxidil sulfate. [1] Minoxidil sulfate is formed from minoxidil via sulfotransferase enzymes, with the predominant enzyme responsible, at least in hair follicles, being SULT1A1. [1] [2] Minoxidil sulfate acts as a potassium channel opener, among other actions, and has vasodilating, hypotensive, and trichogenic or hypertrichotic (hair growth-promoting) effects. [1] [3] Its mechanism of action in terms of hair growth is still unknown, although multiple potential mechanisms have been implicated. [1]

Minoxidil sulfate is a sulfate ester of minoxidil, not a sulfate salt of the compound. [3] However, minoxidil sulfate forms an inner salt, which makes it more hydrophobic than minoxidil. [3] This is in contrast to most sulfate esters, which are usually more hydrophilic than their non-ester forms. [3] The bioactivation of minoxidil into minoxidil sulfate is very unusual and is among the only known instances of sulfation producing a more active drug form. [3] [4] Normally, sulfation tends to inactivate drugs by reducing their biological activity and increasing their excretion. [3] [4]

Minoxidil sulfate is highly unstable in aqueous solutions and alcohol-containing solvents, with a half-life of 6 hours in aqueous solutions and a further much lower half-life in alcohol-containing solvents. [3] This has served as a limiting factor in its potential pharmaceutical use and therapeutic effectiveness. [5] Moreover, minoxidil sulfate has a 40% higher molecular weight than minoxidil, and this may reduce its absorption into the scalp. [5] In any case, a minoxidil sulfate-based topical formulation has been investigated for the treatment of scalp hair loss. [6] [5] Additionally, minoxidil-sulfate-based topical formulations appear to be available for medical use in some parts of the world, for instance in Brazil. [5] [7]

Related Research Articles

<span class="mw-page-title-main">Alopecia areata</span> Condition in which hair is lost from some or all areas of the body

Alopecia areata, also known as spot baldness, is a condition in which hair is lost from some or all areas of the body. Often, it results in a few bald spots on the scalp, each about the size of a coin. Psychological stress and illness are possible factors in bringing on alopecia areata in individuals at risk, but in most cases there is no obvious trigger. People are generally otherwise healthy. In a few cases, all the hair on the scalp is lost, or all body hair is lost. Hair loss can be permanent, or temporary. It is distinct from pattern hair loss, which is common among males.

<span class="mw-page-title-main">Hair loss</span> Loss of hair from the head or body

Hair loss, also known as alopecia or baldness, refers to a loss of hair from part of the head or body. Typically at least the head is involved. The severity of hair loss can vary from a small area to the entire body. Inflammation or scarring is not usually present. Hair loss in some people causes psychological distress.

<span class="mw-page-title-main">Minoxidil</span> Medication used to treat hair loss

Minoxidil, sold under the brand name Rogaine among others, is a medication used for the treatment of high blood pressure and pattern hair loss. It is an antihypertensive vasodilator. It is available as a generic medication by prescription in oral tablet form and over the counter as a topical liquid or foam.

<span class="mw-page-title-main">Tretinoin</span> Medication used for the treatment of acne and acute promyelocytic leukemia

Tretinoin, also known as all-trans retinoic acid (ATRA), is a medication used for the treatment of acne and acute promyelocytic leukemia. For acne, it is applied to the skin as a cream, gel or ointment. For leukemia, it is taken by mouth for up to three months. Topical tretinoin is also the most extensively investigated retinoid therapy for photoaging.

<span class="mw-page-title-main">Ketoconazole</span> Antifungal chemical compound

Ketoconazole, sold under the brand name Nizoral among others, is an antiandrogen and antifungal medication used to treat a number of fungal infections. Applied to the skin it is used for fungal skin infections such as tinea, cutaneous candidiasis, pityriasis versicolor, dandruff, and seborrheic dermatitis. Taken by mouth it is a less preferred option and only recommended for severe infections when other agents cannot be used. Other uses include treatment of excessive male-patterned hair growth in women and Cushing's syndrome.

<span class="mw-page-title-main">Telogen effluvium</span> Medical condition

Telogen effluvium is a scalp disorder characterized by the thinning or shedding of hair resulting from the early entry of hair in the telogen phase. It is in this phase that telogen hairs begin to shed at an increased rate, where normally the approximate rate of hair loss is 125 hairs per day.

<span class="mw-page-title-main">Finasteride</span> Antiandrogen medication

Finasteride, sold under the brand names Proscar and Propecia among others, is a medication used to treat hair loss and benign prostatic hyperplasia (BPH) in men. It can also be used to treat excessive hair growth in women. It is taken by mouth.

The management of hair loss, includes prevention and treatment of alopecia, baldness, and hair thinning, and regrowth of hair.

<span class="mw-page-title-main">Azelaic acid</span> Chemical compound

Azelaic acid (AzA) is an organic compound with the formula HOOC(CH2)7COOH. This saturated dicarboxylic acid exists as a white powder. It is found in wheat, rye, and barley. It is a precursor to diverse industrial products including polymers and plasticizers, as well as being a component of a number of hair and skin conditioners. AzA inhibits tyrosinase.

<span class="mw-page-title-main">Pattern hair loss</span> Medical condition

Pattern hair loss is a hair loss condition that primarily affects the top and front of the scalp. In male-pattern hair loss (MPHL), the hair loss typically presents itself as either a receding front hairline, loss of hair on the crown (vertex) of the scalp, or a combination of both. Female-pattern hair loss (FPHL) typically presents as a diffuse thinning of the hair across the entire scalp.

<span class="mw-page-title-main">SULT1A1</span> Protein-coding gene in the species Homo sapiens

Sulfotransferase 1A1 is an enzyme that in humans is encoded by the SULT1A1 gene.

Anagen effluvium is the pathologic loss of anagen or growth-phase hairs. Classically, it is caused by radiation therapy to the head and systemic chemotherapy, especially with alkylating agents.

<span class="mw-page-title-main">Loose anagen syndrome</span> Medical condition

Loose anagen syndrome, also known as loose anagen hair syndrome, is a hair disorder related to dermatology. It is characterised by the easy and pain free detachment of anagen staged hairs from the scalp. This hair condition can be spontaneous or genetically inherited.

Scarring hair loss, also known as cicatricial alopecia, is the loss of hair which is accompanied with scarring. This is in contrast to non scarring hair loss.

Non scarring hair loss, also known as noncicatricial alopecia is the loss of hair without any scarring being present. There is typically little inflammation and irritation, but hair loss is significant. This is in contrast to scarring hair loss during which hair follicles are replaced with scar tissue as a result of inflammation. Hair loss may be spread throughout the scalp (diffuse) or at certain spots (focal). The loss may be sudden or gradual with accompanying stress.

<span class="mw-page-title-main">Alfatradiol</span> Medication

Alfatradiol, also known as 17α-estradiol and sold under the brand names Avicis, Avixis, Ell-Cranell Alpha, and Pantostin, is a weak estrogen and 5α-reductase inhibitor medication which is used topically in the treatment of pattern hair loss in men and women. It is a stereoisomer of the endogenous steroid hormone and estrogen 17β-estradiol.

<span class="mw-page-title-main">Collagen induction therapy</span>

Collagen induction therapy (CIT), also known as microneedling, dermarolling, or skin needling, is a cosmetic procedure that involves repeatedly puncturing the skin with tiny, sterile needles. CIT should be separated from other contexts in which microneedling devices are used on the skin.

<span class="mw-page-title-main">Topilutamide</span> Chemical compound

Topilutamide, known more commonly as fluridil and sold under the brand name Eucapil, is an antiandrogen medication which is used in the treatment of pattern hair loss in men and women. It is used as a topical medication and is applied to the scalp. Topilutamide belongs to a class of molecules known as perfluoroacylamido-arylpropanamides.

<span class="mw-page-title-main">Setipiprant</span> Chemical compound

Setipiprant (INN; developmental code names ACT-129968, KYTH-105) is an investigational drug developed for the treatment of asthma and scalp hair loss. It was originally developed by Actelion and acts as a selective, orally available antagonist of the prostaglandin D2 receptor 2 (DP2). The drug is being developed as a novel treatment for male pattern baldness by Allergan.

<span class="mw-page-title-main">Calcipotriol/betamethasone dipropionate</span>

Calcipotriol/betamethasone dipropionate, sold under the brand name Taclonex among others, is a fixed-dose combination medication of the synthetic vitamin D3 analog calcipotriol (also known as calcipotriene) and the synthetic corticosteroid betamethasone dipropionate for the treatment of plaque psoriasis. It is used in the form of ointment, topical suspension, gel, aerosol, and foam.

References

  1. 1 2 3 4 5 Gupta AK, Talukder M, Venkataraman M, Bamimore MA (June 2022). "Minoxidil: a comprehensive review". J Dermatolog Treat. 33 (4): 1896–1906. doi:10.1080/09546634.2021.1945527. PMID   34159872. S2CID   235609487.
  2. 1 2 Villani A, Fabbrocini G, Ocampo-Candiani J, Ruggiero A, Ocampo-Garza SS (July 2021). "Review of oral minoxidil as treatment of hair disorders: in search of the perfect dose". J Eur Acad Dermatol Venereol. 35 (7): 1485–1492. doi:10.1111/jdv.17216. PMID   33660357. S2CID   232115094.
  3. 1 2 3 4 5 6 7 Meisheri KD, Johnson GA, Puddington L (January 1993). "Enzymatic and non-enzymatic sulfation mechanisms in the biological actions of minoxidil". Biochem Pharmacol. 45 (2): 271–9. doi:10.1016/0006-2952(93)90061-z. PMID   8435087.
  4. 1 2 Richard B. Silverman (2 December 2012). The Organic Chemistry of Drug Design and Drug Action (2 ed.). Elsevier. pp. 543–. ISBN   978-0-08-051337-9. OCLC   1019583017.
  5. 1 2 3 4 Dias PC, Miot HA, Trüeb RM, Ramos PM (October 2018). "Use of Minoxidil Sulfate versus Minoxidil Base in Androgenetic Alopecia Treatment: Friend or Foe?". Skin Appendage Disord. 4 (4): 349–350. doi:10.1159/000488011. PMC   6219241 . PMID   30410915.
  6. Suchonwanit P, Thammarucha S, Leerunyakul K (2019). "Minoxidil and its use in hair disorders: a review". Drug Des Devel Ther. 13: 2777–2786. doi:10.2147/DDDT.S214907. PMC   6691938 . PMID   31496654.
  7. Kelly, Yanna; Tosti, Antonella (13 September 2019). "Androgenetic Alopecia: Clinical Treatment". Hair and Scalp Treatments. Springer International Publishing. pp. 91–108. doi:10.1007/978-3-030-21555-2_8.